Results 11 to 20 of about 84,900 (313)

Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression [PDF]

open access: yesFrontiers in Endocrinology, 2018
Heparan sulfate (HS) are complex unbranched carbohydrate chains that are heavily modified by sulfate and exist either conjugated to proteins or as free, unconjugated chains. Proteins with covalently bound Heparan sulfate chains are termed Heparan Sulfate
Arvindhan Nagarajan   +3 more
doaj   +4 more sources

Interactions of proteins with heparan sulfate. [PDF]

open access: yesEssays Biochem
Abstract Heparan sulfate (HS) is a glycosaminoglycan, polysaccharides that are considered to have arisen in the last common unicellular ancestor of multicellular animals. In this light, the large interactome of HS and its myriad functions in relation to the regulation of cell communication are not surprising.
Alotaibi FS   +5 more
europepmc   +3 more sources

Heparan Sulfate Proteoglycans [PDF]

open access: yesCold Spring Harbor Perspectives in Biology, 2011
Heparan sulfate proteoglycans are found at the cell surface and in the extracellular matrix, where they interact with a plethora of ligands. Over the last decade, new insights have emerged regarding the mechanism and biological significance of these interactions.
Jeffrey D. Esko   +2 more
openaire   +2 more sources

Roles of Heparan Sulfate Sulfation in Dentinogenesis [PDF]

open access: yesJournal of Biological Chemistry, 2012
Cell surface heparan sulfate (HS) is an essential regulator of cell signaling and development. HS traps signaling molecules, like Wnt in the glycosaminoglycan side chains of HS proteoglycans (HSPGs), and regulates their functions. Endosulfatases Sulf1 and Sulf2 are secreted at the cell surface to selectively remove 6-O-sulfate groups from HSPGs ...
Hayano, S.   +12 more
openaire   +4 more sources

MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides

open access: yesFrontiers in Immunology, 2020
It is well-known that heparin and other glycosaminoglycans (GAGs) inhibit complement activation. It is however not known whether fractionation and/or modification of GAGs might deliver pathway-specific inhibition of the complement system.
Ditmer T. Talsma   +15 more
doaj   +1 more source

Heparan sulfate proteoglycans and cancer [PDF]

open access: yesBritish Journal of Cancer, 2001
Heparan sulfate proteoglycans (HSPGs) are widely distributed in mammalian tissues and involved in a number of processes related to malignancy. They are composed of a core protein to which chains of the glycosaminoglycan, heparan sulfate (HS), are attached.
Blackhall, F. H.   +3 more
openaire   +2 more sources

Shotgun ion mobility mass spectrometry sequencing of heparan sulfate saccharides [PDF]

open access: yes, 2020
Despite evident regulatory roles of heparan sulfate (HS) saccharides in numerous biological processes, definitive information on the bioactive sequences of these polymers is lacking, with only a handful of natural structures sequenced to date.
Grabarics, Márkó   +9 more
core   +1 more source

Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function

open access: yesMatrix Biology Plus, 2022
The glycocalyx attached to the apical surface of vascular endothelial cells is a rich network of proteoglycans, glycosaminoglycans, and glycoproteins with instrumental roles in vascular homeostasis.
Danielle Pretorius   +4 more
doaj   +1 more source

Molecular diversity of heparan sulfate [PDF]

open access: yesJournal of Clinical Investigation, 2001
Heparan sulfate (HS) appeared early in metazoan evolution. As such, many of the structural motifs (variably sulfated disaccharide subunits) that characterize HS (and heparin) were established early on and have been preserved in modern organisms. Thus, many of the biological functions associated with HS either occurred early in evolution or have ...
Jeffrey D. Esko, Ulf Lindahl
openaire   +3 more sources

Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery.

open access: yesPLoS ONE, 2021
BackgroundExperimental cardiac ischemia-reperfusion injury causes degradation of the glycocalyx and coronary washout of its components syndecan-1 and heparan sulfate.
Arie Passov   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy